This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Hepatic and gastrointestinal sarcoidosis

Authoring team

Hepatic or gastrointestinal involvement can be seen in around 18% of patients with sarcoidosis (1).

Liver involvement

  • hepatic granulomas can be found in about 60% - 80% of liver biopsy specimens of patients with sarcoidosis (2). They are more common in patients with bilateral hilar lymphadenopathy alone rather than BHL plus pulmonary infiltrates
  • usually clinically silent, may have constitutional symptoms such as fever, night sweats, anorexia, and weight loss. Liver enlargement is far less frequent (2,3)
  • elevated serum aminotransferase and alkaline phosphatase levels are seen in around 10% of sarcoidosis patients (2)
  • chronic intrahepatic cholestasis, hepatic dysfunction, cirrhosis and portal hypertension are extremely rare and severe complications of sarcoidosis (3)

Gastrointestinal tract

  • gastrointestinal involvement is seen in less than 1% of patients
  • stomach is the most involved part (3), gastric symptoms are uncommon. Granulomas are sometimes reported as incidental findings at post mortem in the stomach
  • small intestine and colon sarcoidosis is uncommon but if present may mimic Crohn’s disease (3)
  • splenic involvement presents with splenomegaly which is usually minimal and asymptomatic (3).

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.